The Nation reports that during the past two decades, university-industry partnerships have become a ubiquitous feature of biotech research, and with this new closeness has come a raft of new concerns about whether the soul of academic science is being slowly eaten away. No one doubts that this surge in alliances has produced enormous scientific progress, yielding important new drugs. The alliances have also hatched many critical tests and medical technologies, prolonging and improving countless lives. But the new alliances have also generated a lot of profit. Unfortunately, the cost of economic success may often be the integrity of the science itself.
This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org
